CN108047258A - A kind of method of synthesizing amino pyridine boronic acid ester - Google Patents

A kind of method of synthesizing amino pyridine boronic acid ester Download PDF

Info

Publication number
CN108047258A
CN108047258A CN201711360278.XA CN201711360278A CN108047258A CN 108047258 A CN108047258 A CN 108047258A CN 201711360278 A CN201711360278 A CN 201711360278A CN 108047258 A CN108047258 A CN 108047258A
Authority
CN
China
Prior art keywords
ester
nitro
boric acid
boronic acid
synthesizing amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201711360278.XA
Other languages
Chinese (zh)
Other versions
CN108047258B (en
Inventor
冷延国
冯学民
王栋召
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou Qinuo Biotechnology Co ltd
Original Assignee
CANGZHOU PURUI ORIENT TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CANGZHOU PURUI ORIENT TECHNOLOGY Co Ltd filed Critical CANGZHOU PURUI ORIENT TECHNOLOGY Co Ltd
Priority to CN201711360278.XA priority Critical patent/CN108047258B/en
Publication of CN108047258A publication Critical patent/CN108047258A/en
Application granted granted Critical
Publication of CN108047258B publication Critical patent/CN108047258B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Abstract

The invention discloses a kind of methods of synthesizing amino pyridine boronic acid ester.Using nitro haloperidid, after Suzuki couplings occur using Metal Palladium and connection boric acid diol ester, after simple filtration, product is obtained after being directly filled with hydrogen reducing.The method provided by method operates, and the other half for avoiding the connection boron ester removed when being coupled in product forms complex compound with aminopyridine, and obtained product purity is high, and yield is good.

Description

A kind of method of synthesizing amino pyridine boronic acid ester
Technical field
The present invention relates to a kind of methods of synthesizing amino pyridine boronic acid ester, belong to medicine intermediate synthesis technical field.
Background technology
Aminopyridine borate is a kind of important medicine intermediate, can be used for further being condensed generation miaow with chloroacetaldehyde Azoles and pyridine compounds can also pass through coupling and generate different types of pharmaceutical intermediate, to meet different clinical stage demands.
Mostly it is directly with being obtained after the directly coupling of connection boric acid diol ester using aminopyridine halides in current synthetic method It arrives, however in actual coupling process, it has been found that there are problems, react the other half and amino formation complex compound removed, no Easily remove, it is especially the most serious with 2-aminopyridine borate.Speculate that reason may be coupled for the amino on aminopyridine Deprotonation under alkaline condition, with falling down another semi-direct be connected with amino after connection boric acid diol ester coupling.It attempted using methanol The methods of reflux, addition acid-base accommodation pH, all effectively removes without obtaining, and according to the product that existing document method obtains, finds not It is very not big with document poor yields, and after repeating document, it obtains product and is detected as sterling through GC, purity more than 98%, Confirm also be simple spike by mass spectrum, molecular weight can coincide with product.However not be pure product after nuclear-magnetism confirms, but Complex compound finds still have part that product is complexed after characterization after recrystallizing repeatedly after methanol eddy.It is and molten due to product Agent degree is very poor, and post-processing operation is just more cumbersome.
The content of the invention
In order to overcome drawbacks described above, the invention discloses a kind of methods of synthesizing amino pyridine boronic acid ester.Using nitro halogen For pyridine, after Suzuki couplings occur using Metal Palladium and connection boric acid diol ester, after simple filtration, hydrogen is directly filled with also Product is obtained after original.
A kind of method of synthesizing amino pyridine boronic acid ester, which is characterized in that including following operation:Nitro haloperidid uses After Suzuki couplings occur for palladium catalyst and connection boric acid diol ester, after simple filtration, obtained after being directly filled with hydrogen reducing Aminopyridine borate.
In the above-mentioned technical solutions, the nitro haloperidid is selected from 2- nitro -3- halogen pyridine, 2- nitro -4- halogen pyrroles Pyridine, 2- nitro -5- halogen pyridine, 3- nitro -5- halogen pyridine, 3- halogen -4- nitropyridines.Halogen is selected from chlorine, bromine or iodine.
In the above-mentioned technical solutions, the boric acid diol ester be selected from connection boric acid neopentyl glycol ester, connection boric acid pinacol ester, Join boric acid pinane diol ester, connection boric acid catechol ester.
In the above-mentioned technical solutions, Suzuki coupling reactions condition is palladium catalyst, under the conditions of solvent, acetic anhydride potassium, It is warming up to 80-120 DEG C of reaction.Solvent selection dioxane, glycol dimethyl ether, toluene, DMSO or DMF;Palladium catalyst uses PdCl2dppf, PdCl2 dppf-CH2Cl2, Pd (PPh3) 4, dichloro [double (di-t-butyl phosphorus) ferrocene of 1,1'-] palladium.
In the above-mentioned technical solutions, the nitro haloperidid, palladium catalyst, connection boric acid diol ester molar ratio are 1: 0.005-0.01:1-1.1.
In the above-mentioned technical solutions, the hydrogen reducing is carried out using under 1-5atm, after reaction, it is molten to add in alcohols It is recrystallized after agent hot melt.
The method provided by method operates, and avoids the other half and ammonia of the connection boron ester removed when being coupled in product Yl pyridines form complex compound, and obtained product purity is high, and yield is good.
Specific embodiment
Embodiment 1
Nitrogen protection under, sequentially added in reaction bulb dioxane 550mL, 2- nitro -5- bromopyridines (20.3g, 0.10mol), connection boric acid pinacol ester (25.4g, 0.10mol), after potassium acetate (14.7g, 0.15mol), after stirring evenly, most Catalyst PdCl2dppf (0.74g, 0.001mol) is added in afterwards, is to slowly warm up to 80-90 DEG C, is stirred to react 2-3h.GC is detected After reaction, cooling stops reaction, and diatomite filtering reacting liquid obtains aterrimus reaction solution, is filled with 1atm hydrogen rear chambers Overnight, after reaction, activated carbon decolorizing, filtrate decompression is distilled to not flow liquid for temperature reaction, adds in ethyl alcohol/heptane mixed solvent drop Temperature mashing half an hour, filtering obtain light grey product 18.5g, and after being heated again using ethyl alcohol, cooling is precipitated, anhydrous with -20 DEG C Ethanol rinse filter cake obtains 16.9g, yield 77%, HPLC purity 99.6%, H NMR (400MHz, DMSO-d6) after drying: 8.16(s,1H),7.54(d,1H),6.39(d,1H),6.30(s, 2H),1.25(s,12H).
Embodiment 2
Nitrogen protection under, sequentially added in reaction bulb dioxane 550mL, 3- nitro -5- bromopyridines (20.3g, 0.10mol), connection boric acid pinacol ester (25.4g, 0.10mol), after potassium acetate (14.7g, 0.15mol), after stirring evenly, most Catalyst PdCl2dppf (0.74g, 0.001mol) is added in afterwards, is to slowly warm up to 80-90 DEG C, is stirred to react 2-3h.GC is detected After reaction, cooling stops reaction, and diatomite filtering reacting liquid obtains aterrimus reaction solution, is filled with 1atm hydrogen rear chambers Overnight, after reaction, activated carbon decolorizing, filtrate decompression is distilled to not flow liquid for temperature reaction, adds in ethyl alcohol/heptane mixed solvent drop Temperature mashing half an hour, filtering obtain light grey crude product, and after being heated again using ethyl alcohol, cooling is precipitated, with -20 DEG C of absolute ethyl alcohols Filter cake is eluted, obtains light yellow solid 15.6g after drying, yield 71%, HPLC purity 97.9%, H NMR (400MHz, CDCl3):8.04(s,1H),7.93(s,1H),7.24(s,1H),6.68(s, 2H),1.23(s,12H).
Embodiment 3
Under nitrogen protection, glycol dimethyl ether 450mL, 2- nitro -3- bromopyridines are sequentially added in reaction bulb (20.3g, 0.10mol), connection boric acid pinacol ester (25.4g, 0.10mol), after potassium acetate (14.7g, 0.15mol), stirring is equal After even, catalyst PdCl2dppf (0.74g, 0.001mol) is eventually adding, 80-90 DEG C is to slowly warm up to, is stirred to react 2-3h. GC is detected after reaction, and cooling stops reaction, and diatomite filtering reacting liquid obtains aterrimus reaction solution, is filled with 1atm hydrogen It is reacted at room temperature after gas overnight, after reaction, activated carbon decolorizing, filtrate decompression is distilled to not flow liquid, adds in ethyl alcohol/heptane mixing Solvent cooling mashing half an hour, filtering obtains light yellow crude product, and after being heated again using ethyl alcohol, cooling is precipitated, with -20 DEG C of nothings Water-ethanol elutes filter cake, and faint yellow solid 16.3g, yield 74%, HPLC purity 98.4%, H NMR are obtained after drying (400MHz,CDCl3):8.06(d,1H),7.34(d,1H),6.59(m, 1H),6.26(s,2H),1.23(s,12H).
Embodiment 4
Nitrogen protection under, sequentially added in reaction bulb DMSO 450mL, 2- nitro -3- bromopyridines (20.3g, 0.10mol), connection boric acid pinacol ester (25.4g, 0.10mol), after potassium acetate (14.7g, 0.15mol), after stirring evenly, most Catalyst Pd (PPh3) 4 (1.16g, 0.001mol) is added in afterwards, is to slowly warm up to 80-90 DEG C, is stirred to react 2-3h.GC is detected After reaction, cooling stops reaction, and diatomite filtering reacting liquid obtains aterrimus reaction solution, evaporated under reduced pressure solvent, again 220mL tetrahydrofurans are added in, are reacted at room temperature overnight after being filled with 3atm hydrogen, after reaction, activated carbon decolorizing, filtrate decompression is steamed It evaporates to not flow liquid, adds in ethyl alcohol/heptane mixed solvent cooling mashing half an hour, filtering obtains light grey crude product, uses again After ethyl alcohol heating, cooling is precipitated, and elutes filter cake with -20 DEG C of absolute ethyl alcohols, off-white powder 17.4g, yield are obtained after drying 79%, HPLC purity 98.2%, H NMR (400MHz, CDCl3): 8.06(d,1H),7.34(d,1H),6.59(m,1H), 6.26(s,2H),1.23(s,12H)。
Embodiment 5
Nitrogen protection under, sequentially added in reaction bulb dioxane 550mL, 2- nitro -4- chloropyridines (15.8g, 0.10mol), connection boric acid pinacol ester (25.4g, 0.10mol), after potassium acetate (14.7g, 0.15mol), after stirring evenly, most Catalyst PdCl2dppf (0.74g, 0.001mol) is added in afterwards, is to slowly warm up to 80-90 DEG C, is stirred to react 2-3h.GC is detected After reaction, cooling stops reaction, and diatomite filtering reacting liquid obtains aterrimus reaction solution, is filled with 1atm hydrogen rear chambers Overnight, after reaction, activated carbon decolorizing, filtrate decompression is distilled to not flow liquid for temperature reaction, adds in ethyl alcohol/heptane mixed solvent drop Temperature mashing half an hour, filtering obtain light grey crude product, and after being heated again using ethyl alcohol, cooling is precipitated, with -20 DEG C of absolute ethyl alcohols Filter cake is eluted, obtains off-white powder 16.5g after drying, yield 75%, HPLC purity 99.1%, HNMR (CDCl3, 400MHz):8.12(s,1H),7.01(s,1H),6.89(s,1H),4.40(s,2H), 1.35(s,12H)。
Embodiment 6
Under nitrogen protection, glycol dimethyl ether 550mL, 2- nitro -4- chloropyridines are sequentially added in reaction bulb (15.8g, 0.10mol), connection boric acid neopentyl glycol ester (22.6g, 0.10mol), after potassium acetate (14.7g, 0.15mol), stirring After uniformly, catalyst PdCl2dppf (0.74g, 0.001mol) is eventually adding, 80-90 DEG C is to slowly warm up to, is stirred to react 2- 3h.GC is detected after reaction, and cooling stops reaction, and diatomite filtering reacting liquid obtains aterrimus reaction solution, is filled with 1atm It is reacted at room temperature after hydrogen overnight, after reaction, activated carbon decolorizing, filtrate decompression is distilled to not flow liquid, is added in ethyl alcohol/heptane and is mixed Bonding solvent cooling mashing half an hour, filtering obtains light yellow crude product, and after being heated again using ethyl alcohol, cooling is precipitated, with -20 DEG C Absolute ethyl alcohol elutes filter cake, and off-white powder 14.8g, yield 72%, HPLC purity 99.0%, HNMR are obtained after drying (CDCl3,400MHz):8.12(s,1H),7.01(s,1H),6.89(s,1H), 4.40(s,2H),1.35(s,12H)。
Embodiment 7
Nitrogen protection under, sequentially added in reaction bulb dioxane 550mL, 2- nitro -5- chloropyridines (15.8g, 0.10mol), boric acid neopentyl glycol ester (22.6g, 0.10mol) is joined, after potassium acetate (14.7g, 0.15mol), after stirring evenly, Catalyst PdCl2dppf (0.74g, 0.001mol) is eventually adding, 80-90 DEG C is to slowly warm up to, is stirred to react 2-3h.GC is examined It surveys after reaction, cooling stops reaction, and diatomite filtering reacting liquid obtains aterrimus reaction solution, after being filled with 3atm hydrogen Overnight, after reaction, activated carbon decolorizing, filtrate decompression is distilled to not flow liquid, adds in ethyl alcohol/heptane mixed solvent for room temperature reaction Cooling mashing half an hour, filtering obtain off-white color product, and after being heated again using ethyl alcohol, cooling is precipitated, with -20 DEG C of anhydrous second Alcohol elutes filter cake, obtains off-white powder 14.0g after drying, yield 68%, HPLC purity 98.9%, H NMR (400MHz, DMSO-d6):8.16(s,1H),7.54(d,1H),6.39 (d,1H),6.30(s,2H),3.78(s,4H),0.95(s,6H).
Embodiment 8
Nitrogen protection under, sequentially added in reaction bulb toluene 750mL, 3- nitro -5- chloropyridines (15.8g, 0.10mol), boric acid neopentyl glycol ester (22.6g, 0.10mol) is joined, after potassium acetate (24.5g, 0.25mol), after stirring evenly, Catalyst PdCl2dppf (0.74g, 0.001mol) is eventually adding, 100-105 DEG C is to slowly warm up to, is stirred to react 8-10h.GC After reaction, cooling stops reaction for detection, and diatomite filtering reacting liquid obtains aterrimus reaction solution, adds in 100mL ethyl alcohol Afterwards, reacted at room temperature overnight after being filled with 3atm hydrogen, after reaction, activated carbon decolorizing, filtrate decompression is distilled to not flow liquid, is added in Ethyl alcohol/heptane mixed solvent cooling mashing half an hour, filtering obtain light grey product, again using ethyl alcohol dissolubility after, cooling analysis Go out, elute filter cake with -20 DEG C of absolute ethyl alcohols, light yellow solid 15.2g, yield 74%, HPLC purity are obtained after drying 98.1%, H NMR (400MHz, CDCl3):8.04(s,1H),7.93(s,1H), 7.24(s,1H),6.68(s,2H),1.23 (s,12H)。

Claims (7)

  1. A kind of 1. method of synthesizing amino pyridine boronic acid ester, which is characterized in that including following operation:
    After using palladium catalyst and connection boric acid diol ester Suzuki couplings occur for nitro haloperidid, after simple filtration, directly It connects and obtains aminopyridine borate after being filled with hydrogen reducing.
  2. 2. according to a kind of method of synthesizing amino pyridine boronic acid ester of claim 1, it is characterised in that:The nitro haloperidid choosing From 2- nitro -3- halogen pyridine, 2- nitro -4- halogen pyridine, 2- nitro -5- halogen pyridine, 3- nitro -5- halogen pyridine, 3- halogen -4- nitros Pyridine.
  3. 3. according to a kind of method of synthesizing amino pyridine boronic acid ester of claim 2, it is characterised in that:The halogen is selected from chlorine, bromine Or iodine.
  4. 4. according to a kind of method of synthesizing amino pyridine boronic acid ester of claim 1, it is characterised in that:The boric acid diol ester choosing From connection boric acid neopentyl glycol ester, connection boric acid pinacol ester, connection boric acid pinane diol ester, connection boric acid catechol ester.
  5. 5. according to a kind of method of synthesizing amino pyridine boronic acid ester of claim 1, it is characterised in that:The palladium catalyst uses PdCl2dppf, PdCl2dppf-CH2Cl2, Pd (PPh3) 4 or dichloro [double (di-t-butyl phosphorus) ferrocene of 1,1'-] palladium.
  6. 6. according to a kind of method of synthesizing amino pyridine boronic acid ester of claim 1, it is characterised in that:The nitro haloperidid, Palladium catalyst, connection boric acid diol ester molar ratio are 1:0.005-0.01:1-1.1.
  7. 7. according to a kind of method of synthesizing amino pyridine boronic acid ester of claim 1, it is characterised in that:The hydrogen reducing uses It carries out under 1-5atm, after reaction, is recrystallized after adding in alcohols solvent hot melt.
CN201711360278.XA 2017-12-17 2017-12-17 Method for synthesizing aminopyridine borate Active CN108047258B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711360278.XA CN108047258B (en) 2017-12-17 2017-12-17 Method for synthesizing aminopyridine borate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711360278.XA CN108047258B (en) 2017-12-17 2017-12-17 Method for synthesizing aminopyridine borate

Publications (2)

Publication Number Publication Date
CN108047258A true CN108047258A (en) 2018-05-18
CN108047258B CN108047258B (en) 2020-06-30

Family

ID=62133503

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711360278.XA Active CN108047258B (en) 2017-12-17 2017-12-17 Method for synthesizing aminopyridine borate

Country Status (1)

Country Link
CN (1) CN108047258B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109467569A (en) * 2018-12-23 2019-03-15 沧州普瑞东方科技有限公司 The synthetic method of 3- amino phenyl boric acid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102399218A (en) * 2010-09-16 2012-04-04 和记黄埔医药(上海)有限公司 Triheterocyclic compounds and their use as PI3K inhibitors
CN103124731A (en) * 2010-09-16 2013-05-29 和记黄埔医药(上海)有限公司 Fused heteroaryls and their uses
WO2017149463A1 (en) * 2016-03-01 2017-09-08 Novartis Ag Cyano-substituted indole compounds and uses thereof as lsd1 inhibitors
CN107383076A (en) * 2017-06-29 2017-11-24 吉尔生化(上海)有限公司 A kind of synthetic method of the chlorophenylboronic acid pinacol ester of 3 amino 4

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102399218A (en) * 2010-09-16 2012-04-04 和记黄埔医药(上海)有限公司 Triheterocyclic compounds and their use as PI3K inhibitors
CN103124731A (en) * 2010-09-16 2013-05-29 和记黄埔医药(上海)有限公司 Fused heteroaryls and their uses
WO2017149463A1 (en) * 2016-03-01 2017-09-08 Novartis Ag Cyano-substituted indole compounds and uses thereof as lsd1 inhibitors
CN107383076A (en) * 2017-06-29 2017-11-24 吉尔生化(上海)有限公司 A kind of synthetic method of the chlorophenylboronic acid pinacol ester of 3 amino 4

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GISELE A.NISHIGUCHI等: ""Design and Discovery of N‑(2-Methyl-5′-morpholino-6′-((tetrahydro‑2H‑pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide(RAF709):A Potent,Selective,and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers"", 《J.MED.CHEM.》 *
卢汝梅 等主编: "《波谱分析》", 31 August 2014, 北京:中国中医药出版社 *
姚其正 主编: "《药物合成反应》", 30 September 2012, 北京:中国医药科技出版社 *
邢其毅等: "《基础有机化学.上册》", 30 June 2005, 北京:高等教育出版社 *
郭春 主编: "《药物合成反应实验》", 31 January 2007, 北京:中国医药科技出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109467569A (en) * 2018-12-23 2019-03-15 沧州普瑞东方科技有限公司 The synthetic method of 3- amino phenyl boric acid

Also Published As

Publication number Publication date
CN108047258B (en) 2020-06-30

Similar Documents

Publication Publication Date Title
CN102639486A (en) Process for manufacture of N-acylbphenyl alanine
CN107176955A (en) A kind of Ba Rui replaces the preparation method of Buddhist nun
CN106243105B (en) Methylene-bridged 1,8- naphthyridines ligand and copper (I) complex, preparation method and application
CN107200705B (en) A kind of preparation method of 3- nitro -2- indolone derivatives
CN102367260A (en) Synthesis method of 2-aminopyrimidine-5-boric acid
CN107540678B (en) Method for preparing coumarin heteroaromatic ring compound and derivative thereof through intramolecular cross dehydrogenation coupling
CN108047258A (en) A kind of method of synthesizing amino pyridine boronic acid ester
CN103980188B (en) The synthetic method of a kind of pyrrole Lun Panai and the synthetic method of intermediate and intermediate thereof
CN105732619A (en) Synthesizing method of 5,6,7,8-tetrahydropyridino-[2,3-d]pyrimidine compound
CN113045503B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound and application of compound in synthesis of drug molecules
CN112457339A (en) Synthetic method of pyrrole [1,2-a ] quinoxaline derivative
CN108864164B (en) Synthesis method of primary amine-guided 2-alkynyl indole compound
CN106831768A (en) A kind of synthetic method of 2,6 dichloropyridines [3,4 B] pyrazine
JPH02204481A (en) Preparation of pyridine-2, 3-dicarboxylic acid ester
CN113896732B (en) Preparation method and application of anticancer drug carbamatinib
CN111484436A (en) Method for introducing isopentenyl group to C3 position of indole
CN112159360B (en) Preparation method of 2-dimethylamino-6-benzylamino substituted triazine compound
CN104016917A (en) 5,6-dihydrophenanthridine compound and preparation method thereof
CN102786543A (en) Preparation methods for imidazole[1,2-a]pyridine-6-boric acid pinacol ester and derivatives thereof
CN104230689B (en) 6,7-dihydro-5H-hexichol [a, c] ring heptan-5-ketone compounds and preparation method thereof
CN101723854A (en) Preparation method of 6-substituted amino-3-cyano quinoline compound and midbody thereof
CN104513231A (en) Synthetic method for lapatinib and lapatinib intermediates
CN105037261B (en) A kind of method for synthesizing milrinone
CN112209867B (en) Synthetic method of 2-alkynyl substituted indole compound
CN103242223A (en) Preparation method of 2-pyridineoxydiaryl ketone derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20221108

Address after: Room 2-101, Building 3, No. 70 Qingyang Road, Xinbei District, Changzhou City, Jiangsu Province, 213000

Patentee after: Changzhou Qinuo Biotechnology Co.,Ltd.

Address before: 061108 Jingwu Road, Lingang Economic and Technological Development Zone, Huanghua City, Cangzhou City, Hebei Province

Patentee before: CANGZHOU PURUI DONGFANG SCIENCE & TECHNOLOGY Co.,Ltd.